BioXcel plans to lay off 110 workers, or 58% of its workforce, as part of a restructuring that aims to reduce the biotech’s cash burn.
BioXcel currently has 190 employees, and it said Monday in its second-quarter earnings release that the workforce reductions will primarily impact BioXcel’s commercial organization. The company wants to reduce its cash burn by 50% to around $80 million a year. It currently has enough cash to last through the middle of next year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.